JV Termination and Takeover Discussions

Notice of Joint Venture Termination Delivered; Acquisition Discussions Underway

Standard Vape Corporation (SVAP OTC Pink) announced today that its wholly owned subsidiary Neo-Virucide, Inc. (NVI) (www.neovirucide.com) and the Licensor of the NanoNOx™ technology from NMB Therapeutics, Inc. (NMB) has sent a Notice of Termination to its Joint Venture Partner Vivian Li Kremer Co., citing failure to fund among other reasons for the termination

Standard Vape also announced that acquisition discussions are being held concerning two subsidiaries of a German public company in the financial technology sector. The object of the discussions would most likely result, if successful, in a divestiture of other businesses and a reverse takeover of Standard Vape.

Legal Disclaimer

This release contains forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended and section 21e of the Securities and Exchange Act of 1934, as amended. Those statements include the intent, belief or current expectations of the company and its management team. Forward-looking statements are projections of events, revenues, income, future economics, research, development, reformulation, product performance or management's plans and objectives for future operations. Some or all the events or results anticipated by these forward-looking statements may not occur. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Accomplishing the strategy described herein is significantly dependent upon numerous factors, many that are not in management's control.

Contact Information Roger Fidler NVI President (201) 220-8734 rfidler0099@aol.com

Brinsley Holman +44 (0)7776 30 22 28 brinsley.holman@kbrl.co.uk.